Antimicrobial Resistance: What Is Being Done?

It has been 8 years since the Review on Antimicrobial Resistance "Tackling Drug-Resistant Infections Globally" was published. This is often referred to more colloquially as "The O'Neill report on antimicrobial resistance". The report presents AMR as a critical global health threat that could lead to 10 million deaths per year by 2050, with a $100 trillion economic cost. It highlights the growing crisis of drug-resistant infections, driven by overuse and misuse of antibiotics in humans and animals, lack of new drugs, and poor global health infrastructure.

Cost of tackling AMR

The report estimates that the cost of a global strategy to address AMR would be around $40 billion over 10 years. It compares this to the significantly higher costs of inaction, both in human lives and economic loss. The report highlights that much of this funding could come from reallocating resources from existing health and economic development budgets or creating new funding streams such